Healthcare Map
The industry's most comprehensive and complete source of deidentified patient-level data
Platform · Cloud SaaSCompany source
Company profile
About Komodo Health
Komodo Health is a healthcare intelligence platform that combines the industry's most comprehensive real-world data foundation with purpose-built AI to deliver verified, defensible answers for complex healthcare questions. The company's Healthcare Map aggregates over 1 trillion linked records covering 330+ million de-identified patients, refreshed daily, creating the most complete view of U.S. patient journeys available. This data foundation powers Marmot, Komodo's healthcare-native AI system designed specifically for the complexity of healthcare analytics. Unlike generic AI models, Marmot is built to be reproducible, traceable, and governed—showing its work on every analysis. The platform has been validated across more than 1 million real analyses, enabling teams to move from question to verified answer in minutes rather than weeks. Komodo serves life sciences companies across commercial, HEOR, medical affairs, and clinical development functions, as well as financial services firms, payers, providers, and consultancies. The company's approach eliminates the traditional trade-off between speed and accuracy in healthcare analytics. By integrating 60+ data sources at the patient level and applying healthcare-specific AI methods, Komodo enables organizations to ask complex questions in plain language and receive auditable insights fast enough to act on. The platform supports use cases from KOL identification and patient population sizing to real-world evidence generation and market signal detection. With offices in New York City, San Francisco, Silicon Valley, Chicago, and Chennai, Komodo Health is transforming how healthcare decisions are made by providing intelligence that organizations can confidently stand behind.
Company description Komodo Health official website
Primary marketGenerative AI & Healthcare Infrastructure
Commercial modelCommercial information available on request
Work at Komodo Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Consultancies
- Financial Services
- Healthcare Agencies
- Life Sciences
- Payers
- Pharma
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Latest Marmot platform updates including plain language query capabilities, Home dashboard for unified view, direct Healthcare Map integration with user tools, enhanced provider data tracking
Partnerships
Recorded partners
- Fight CRC
- Novo Nordisk
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Marmot
Reproducible, traceable, and governed AI insights you can defend and show the work
Platform · Cloud SaaSCompany source
Marmot Development Kit
Put the Healthcare Map directly in your Snowflake, Databricks, or Python environment
Api · HybridCompany source
Marmot Navigator
Ask any question in plain language and get an answer you can use
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Real-world treatment adherence and persistence among patients initiating inclisiran or PCSK9 mAbs.American journal of preventive cardiology · Dec 1, 2026
Association of systemic inflammation with major adverse cardiovascular events in patients with acute myocardial infarction.American journal of preventive cardiology · Oct 1, 2026
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments.Inflammatory bowel diseases · Jul 28, 2026
Pain medication use in patients with X-linked hypophosphatemia treated with burosumab: a retrospective real-world study.JBMR plus · May 1, 2026
Risk of serious infections, myocardial infarction or stroke, venous thromboembolic events, and malignancy in patients with psoriatic arthritis treated with tofacitinib compared with biologic treatments in the United States.Arthritis research & therapy · Mar 25, 2026
A Metabolism-Informed Neural Network Identifies Pathways Influencing the Potency and Toxicity of Antimicrobial Combinations.npj drug discovery · Jan 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Study completion time reduced from 6 months to weekend
Novo Nordisk clinical data science team using Marmot
2.3X higher accuracy vs foundational models
Benchmarking Marmot against frontier AI models in healthcare analytics
Alnylam Pharmaceuticals
Accelerating analytics work and reducing time spent on data preparation
Teams spend less time figuring out how to get work done and more time working on behalf of patients; moved week-long analysis to minutes
Fairview Health Services
Healthcare analytics and insights generation for pharmacy services
Analysis that used to take months now takes minutes; helped answer questions not even thought to ask
Fight CRC
Democratized access to essential healthcare data to identify where care is breaking down and where intervention is needed most to drive meaningful policy change
Enabled identification of care breakdown points and intervention opportunities to save lives
Merck
Pharmaceutical commercial AI agents and analytics acceleration
Marmot felt like having own Chief of Staff with advantage carrying through to whole team
Novo Nordisk
Accelerated clinical data science and evidence generation studies using Marmot platform
Reduced study completion time from 6 months to a single weekend in shortest case
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Web Sun
President and Co-Founder
Charles Ellis
Area Vice President, Emerging Life Sciences
Faraz Farange ☁️
Area Vice President, Life Sciences
Julia DeFeo
Area Vice President, Emerging Life Sciences
Stacy Levy
Vice President of Sales at Genomind
Lesley Downes
Area Vice President- Real World Evidence, HEOR
Eduardo Lobo
Executive Assistant to CFO and CBO
Tori Ehrhardt
Executive Chief of Staff
06 · Company updates
Updates from Komodo Health
Recent articles published on Komodo Health's official website.
The Best Forecasts Start From Sharper Observation
Read on Komodo HealthThe Evidence Paradox: AI Is Generating More RWE Than Ever, and Most of It Won’t Hold Up
Read on Komodo HealthThe AI Maturity Model for Life Sciences: A Four-Phase Field Guide
Read on Komodo HealthThe Hidden Assumption Stack: Building Trust in AI-Generated RWE
Read on Komodo HealthUneven Terrain: How Local Real-World Insights Can Improve Kidney Cancer Outcomes
Read on Komodo Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Generative AI & Healthcare Infrastructure
Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.